VBI VACCINES INC (VBIV) Forecast, Price Target & Analyst Ratings

NASDAQ:VBIVCA91822J2020

Current stock price

0.0653 USD
-0.07 (-50.87%)
At close:
0.045 USD
-0.02 (-31.09%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VBI VACCINES INC (VBIV).

Forecast Snapshot

Consensus Price Target

Price Target
$5.10
+ 7,710.11% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 12, 2024
Period
Q2 / 2024
EPS Estimate
-$0.33
Revenue Estimate
3.253M

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.10
Upside
+ 7,710.11%
From current price of $0.07 to mean target of $5.10, Based on 7 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for VBIV. The average price target is 5.1 USD. This implies a price increase of 7710.11% is expected in the next year compared to the current price of 0.0653.

Analyst Ratings & History

Current Analyst Ratings

VBIV Current Analyst RatingVBIV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

VBIV Historical Analyst RatingsVBIV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
VBIV was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VBIV.
In the previous month the buy percentage consensus was at a similar level.
VBIV was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-04-13Raymond JamesMaintains Outperform
2022-11-11Raymond JamesDowngrade Strong Buy -> Outperform
2022-08-09Raymond JamesMaintains Strong Buy
2022-03-08Raymond JamesMaintains Strong Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 12, 2024
Period
Q2 / 2024
EPS Estimate
-$0.33
Revenue Estimate
3.253M
Revenue Q2Q
351.81%
EPS Q2Q
93.54%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
31.91%

Next Earnings Summary

VBIV is expected to report earnings on 11/12/2024. The consensus EPS estimate for the next earnings is -0.33 USD and the consensus revenue estimate is 3.25M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
VBIV revenue by date.VBIV revenue by date.
630K
-40.57%
1.08M
71.43%
8.682M
703.89%
13.101M
50.90%
34.805M
165.67%
60.017M
72.44%
EBITDA
YoY % growth
VBIV ebitda by date.VBIV ebitda by date.
-66.19M
-57.71%
-79.76M
-20.50%
-53.321M
33.15%
N/AN/AN/A
EBIT
YoY % growth
VBIV ebit by date.VBIV ebit by date.
-68.03M
-55.96%
-81.82M
-20.27%
-55.311M
32.40%
-38.258M
30.83%
-20.415M
46.64%
-15.604M
23.57%
Operating Margin
VBIV operating margin by date.VBIV operating margin by date.
-10,798.41%-7,575.93%-637.08%-292.02%-58.66%-26.00%
EPS
YoY % growth
VBIV eps by date.VBIV eps by date.
-0.27
-28.57%
-0.43
-59.26%
-9.29
-2,060.47%
-1.25
86.50%
-0.29
77.24%
-0.23
17.86%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.33
93.54%
-0.22
77.78%
-0.15
-1,430.00%
-0.12
83.23%
-0.09
71.88%
-0.05
77.27%
-0.03
80.00%
Revenue
Q2Q % growth
3.253M
351.81%
3.955M
-40.29%
4.655M
445.72%
6.68M
450.25%
7.959M
144.67%
9.475M
139.57%
10.691M
129.67%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-10.044M
40.81%
-9.259M
-43.10%
-8.479M
31.42%
-6.718M
42.84%
-5.707M
43.18%
-4.465M
51.78%
-3.527M
58.40%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VBIV Yearly Revenue VS EstimatesVBIV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
VBIV Yearly EPS VS EstimatesVBIV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.46%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
64.62%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

VBI VACCINES INC / VBIV Forecast FAQ

What do analysts expect the price target to be for VBI VACCINES INC (VBIV)?

7 analysts have analysed VBIV and the average price target is 5.1 USD. This implies a price increase of 7710.11% is expected in the next year compared to the current price of 0.0653.

Can you provide the upcoming earnings date for VBI VACCINES INC?

VBI VACCINES INC (VBIV) will report earnings on 2024-11-12, before the market open.

What are the consensus estimates for VBI VACCINES INC (VBIV) next earnings?

The consensus EPS estimate for the next earnings of VBI VACCINES INC (VBIV) is -0.33 USD and the consensus revenue estimate is 3.25M USD.

How many analysts cover VBI VACCINES INC (VBIV) stock?

The number of analysts covering VBI VACCINES INC (VBIV) is 7.